- Home
- NRXP vs PASG Comparison
NRXP vs PASG Comparison
Compare NRXP & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- PASG
- Stock Information
- Founded
- NRXP 2015
- PASG 2017
- Country
- NRXP United States
- PASG United States
- Employees
- NRXP N/A
- PASG N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- NRXP Health Care
- PASG Health Care
- Exchange
- NRXP Nasdaq
- PASG Nasdaq
- Market Cap
- NRXP 51.3M
- PASG 42.2M
- IPO Year
- NRXP N/A
- PASG 2020
- Fundamental
- Price
- NRXP $2.28
- PASG $0.52
- Analyst Decision
- NRXP Strong Buy
- PASG Strong Buy
- Analyst Count
- NRXP 3
- PASG 3
- Target Price
- NRXP $31.67
- PASG $8.00
- AVG Volume (30 Days)
- NRXP 464.9K
- PASG 138.4K
- Earning Date
- NRXP 03-27-2025
- PASG 03-03-2025
- Dividend Yield
- NRXP N/A
- PASG N/A
- EPS Growth
- NRXP N/A
- PASG N/A
- EPS
- NRXP N/A
- PASG N/A
- Revenue
- NRXP N/A
- PASG N/A
- Revenue This Year
- NRXP N/A
- PASG N/A
- Revenue Next Year
- NRXP N/A
- PASG N/A
- P/E Ratio
- NRXP N/A
- PASG N/A
- Revenue Growth
- NRXP N/A
- PASG N/A
- 52 Week Low
- NRXP $1.10
- PASG $0.45
- 52 Week High
- NRXP $7.33
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- NRXP 38.85
- PASG 39.73
- Support Level
- NRXP $2.80
- PASG $0.52
- Resistance Level
- NRXP $3.07
- PASG $0.60
- Average True Range (ATR)
- NRXP 0.29
- PASG 0.05
- MACD
- NRXP -0.10
- PASG 0.00
- Stochastic Oscillator
- NRXP 2.52
- PASG 20.37
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.